Cargando…
Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer
Glycoprotein non-metastatic B (GPNMB), a type I transmembrane glycoprotein, is overexpressed in melanoma and breast cancer and promotes cancer-cell invasion and motility. We previously reported cross-talk between GPNMB and human epidermal growth factor receptor 2 (HER2) in breast cancer, suggesting...
Autores principales: | Tajima, Jesse Yu, Futamura, Manabu, Gaowa, Siqin, Mori, Ryutaro, Tanahashi, Toshiyuki, Tanaka, Yoshihiro, Matsuhashi, Nobuhisa, Takahashi, Takao, Yamaguchi, Kazuya, Miyazaki, Tatsuhiko, Yoshida, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771343/ https://www.ncbi.nlm.nih.gov/pubmed/29344282 http://dx.doi.org/10.7150/jca.20266 |
Ejemplares similares
-
Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status
por: Kato, Junko, et al.
Publicado: (2016) -
Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer
por: Kanematsu, Masako, et al.
Publicado: (2015) -
The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells
por: Mori, Ryutaro, et al.
Publicado: (2018) -
Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
por: Tanaka, Yoshihiro, et al.
Publicado: (2016) -
Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
por: Tanaka, Yoshihiro, et al.
Publicado: (2016)